Cyclerion Therapeutics (CYCN) Operating Income Growth (3y) (2021 - 2025)
Cyclerion Therapeutics (CYCN) Operating Income Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Op. Inc Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Cyclerion Therapeutics |
11.50 Mn |
8.26 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
39.39% |
| Jun 30, 2025 |
50.07% |
| Mar 31, 2025 |
51.77% |
| Dec 31, 2024 |
26.72% |
| Sep 30, 2024 |
53.59% |
| Jun 30, 2024 |
55.94% |
| Mar 31, 2024 |
50.57% |
| Dec 31, 2023 |
54.63% |
| Sep 30, 2023 |
34.88% |
| Jun 30, 2023 |
54.40% |
| Mar 31, 2023 |
45.82% |
| Dec 31, 2022 |
44.87% |
| Sep 30, 2022 |
45.57% |
| Jun 30, 2022 |
25.93% |
| Mar 31, 2022 |
29.71% |
| Dec 31, 2021 |
22.58% |
| Sep 30, 2021 |
27.23% |
| Jun 30, 2021 |
18.41% |
| Mar 31, 2021 |
19.08% |
